Filing Details
- Accession Number:
- 0001123292-17-000719
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-03-20 15:25:19
- Reporting Period:
- 2017-02-17
- Filing Date:
- 2017-03-20
- Accepted Time:
- 2017-03-20 15:25:19
- Original Submission Date:
- 2017-02-21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1588972 | Recro Pharma Inc. | REPH | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398330 | Scp Vitalife Partners Ii Lp | Suite 190 7 Great Valley Parkway Malvern PA 19355 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-02-17 | 9,983 | $7.59 | 2,292,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2016.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.45 to $7.84, inclusive. The reporting person undertakes to provide Recro Pharma, Inc., any security holder of Recro Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
- This amendment corrects a previous clerical error to the "Amount of Securities Beneficially Owned Following Reported Transaction" contained in the Form 4 filed on February 21, 2017.
Billionaire Hedge Funds
